New pill targets hard-to-treat cancers with rare mutation
NCT ID NCT06386146
First seen Jan 28, 2026 · Last updated May 01, 2026 · Updated 10 times
Summary
This study tests an experimental drug called JAB-30355 in adults with advanced solid tumors that have a specific TP53 Y220C mutation. The main goals are to check safety and find the right dose, while also seeing if the drug can shrink tumors. About 144 participants who have already tried at least one other cancer treatment will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGDenver, Colorado, 80218, United States
-
Research Site
RECRUITINGNashville, Tennessee, 37203, United States
-
Research Site
RECRUITINGBeijing, Beijing Municipality, 100000, China
-
Research Site
RECRUITINGBeijing, Beijing Municipality, 100021, China
-
Research Site
RECRUITINGBeijing, Beijing Municipality, 100142, China
-
Research Site
NOT_YET_RECRUITINGGuangzhou, Guangdong, 510000, China
-
Research Site
NOT_YET_RECRUITINGJinan, Shandong, 250117, China
-
Research Site
RECRUITINGShanghai, Shanghai Municipality, 200032, China
-
Research site
RECRUITINGLake Mary, Florida, 32771, United States
-
Research site
RECRUITINGSt Louis, Missouri, 63110, United States
-
Research site
TERMINATEDCanton, Ohio, 44718, United States
-
Research site
RECRUITINGCleveland, Ohio, 44195, United States
-
Research site
RECRUITINGHouston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.